Jennifer Gibbins, MBA
About Jennifer Gibbins, MBA
Jennifer Gibbins, MBA, serves as the Director of Project Management Medical and Scientific Activities at Secura Bio, Inc. She has over 26 years of experience in the biotechnology industry, holding advanced degrees in business and a Bachelor of Science in Chemistry.
Work at Secura Bio
Jennifer Gibbins has been serving as the Director of Project Management Medical and Scientific Activities at Secura Bio, Inc. since 2021. In this role, she oversees various projects related to medical and scientific initiatives. Her tenure at Secura Bio spans three years, during which she has contributed to the company's objectives in the biotechnology sector. The company is located in Camarillo, California, United States.
Education and Expertise
Jennifer Gibbins holds multiple degrees, including a Master of Business Administration (MBA) with a focus on Entrepreneurship, Innovation, and Global Leadership from Syracuse University. She also completed a Master's degree in Business Analytics from the same institution. Additionally, she earned a Doctor of Management degree from the University of Maryland Global Campus, where her thesis focused on systems theories applied to the global expansion of biotechnology companies. She possesses a Bachelor of Science degree in Chemistry from the University of Colorado Denver.
Background
Jennifer Gibbins has over 26 years of experience in the biotechnology industry. Her career includes significant roles at various organizations, such as Proligo, Amgen, and Bristol-Myers Squibb. At Amgen, she worked as a Senior Manager in Global Regulatory Affairs and Safety for 15 years. Her earlier experience includes positions at the University of Colorado Hospital Authority and as an Associate Scientist at Bristol-Myers Squibb.
Achievements
Throughout her career, Jennifer Gibbins has managed groups and led continuous improvement initiatives. She has defined strategies in her professional roles and has experience in managing budgets and performing financial analysis. Her extensive background in quality, operations, and strategy within the biotechnology sector underscores her expertise and leadership capabilities.